Regen BioPharma Inc (RGBP):企業の財務・戦略的SWOT分析

◆英語タイトル:Regen BioPharma Inc (RGBP) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14808
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Regen BioPharma Inc (Regen BioPharma), a subsidiary of Bio-Matrix Scientific Group Inc, is an immunology and immunotherapy space provider. The company concentrates on the development of immunotherapies and cancer stem cell therapies. Its product pipeline includes HemaXellerate, dCellVax, DiffronC, small molecule targeting cancer stem cell genes, telomeres and genomic integrity. Regen BioPharma provides products for aplastic anemia, myelodysplastic syndrome, solid tumors and acute leukemia, breast cancer, hematopoiesis and liver cancer, among others. The company spans its expertise in the development of therapies including small molecules, stem cell treatments and the body’s own immune system. Regen BioPharma is headquartered in La Mesa, California, the US.

Regen BioPharma Inc Key Recent Developments

Nov 13,2018: Regen BioPharma reports additional new NR2F6 small molecule inhibitors

This comprehensive SWOT profile of Regen BioPharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Regen BioPharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Regen BioPharma Inc – Key Information
Regen BioPharma Inc – Overview
Regen BioPharma Inc – Key Employees
Regen BioPharma Inc – Key Employee Biographies
Regen BioPharma Inc – Key Operational Heads
Regen BioPharma Inc – Major Products and Services
Regen BioPharma Inc – History
Regen BioPharma Inc – Company Statement
Regen BioPharma Inc – Locations And Subsidiaries
Regen BioPharma Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Regen BioPharma Inc – Business Description
Regen BioPharma Inc – Corporate Strategy
Regen BioPharma Inc – SWOT Analysis
SWOT Analysis – Overview
Regen BioPharma Inc – Strengths
Regen BioPharma Inc – Weaknesses
Regen BioPharma Inc – Opportunities
Regen BioPharma Inc – Threats
Regen BioPharma Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Regen BioPharma Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Regen BioPharma Inc, Key Information
Regen BioPharma Inc, Key Ratios
Regen BioPharma Inc, Share Data
Regen BioPharma Inc, Major Products and Services
Regen BioPharma Inc, History
Regen BioPharma Inc, Key Employees
Regen BioPharma Inc, Key Employee Biographies
Regen BioPharma Inc, Key Operational Heads
Regen BioPharma Inc, Other Locations
Regen BioPharma Inc, Subsidiaries
Regen BioPharma Inc, Key Manufacturing facilities
Regen BioPharma Inc, Key Competitors
Regen BioPharma Inc, SWOT Analysis
Regen BioPharma Inc, Ratios based on current share price
Regen BioPharma Inc, Annual Ratios
Regen BioPharma Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Regen BioPharma Inc, Performance Chart
Regen BioPharma Inc, Ratio Charts

★海外企業調査レポート[Regen BioPharma Inc (RGBP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sampo plc:企業のM&A・事業提携・投資動向
    Sampo plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sampo plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Intellipharmaceutics International Inc (IPCI):企業の財務・戦略的SWOT分析
    Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Tampa Electric Co:電力:M&Aディール及び事業提携情報
    Summary Tampa Electric Company (TEC), a subsidiary of Emera Inc., is an energy utility. It conducts the generation, purchase, transmission, distribution and sale of electricity and the distribution, purchase and sale of natural gas in Florida. The service area for electric operations covers West Cen …
  • Harley-Davidson Inc (HOG):企業の財務・戦略的SWOT分析
    Harley-Davidson Inc (HOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bollore SA (BOL):企業の財務・戦略的SWOT分析
    Bollore SA (BOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • ShanPar Industries Pvt. Ltd. :企業の戦略・SWOT・財務情報
    ShanPar Industries Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary ShanPar Industries Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Senior Plc:企業の戦略・SWOT・財務情報
    Senior Plc - Strategy, SWOT and Corporate Finance Report Summary Senior Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Delaware North:企業の戦略・SWOT・財務分析
    Delaware North - Strategy, SWOT and Corporate Finance Report Summary Delaware North - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Mastek Ltd (MASTEK):企業の財務・戦略的SWOT分析
    Mastek Ltd (MASTEK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Wanhua Chemical Group Co Ltd (600309):企業の財務・戦略的SWOT分析
    Wanhua Chemical Group Co Ltd (600309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Hikal Ltd (HIKAL):企業の財務・戦略的SWOT分析
    Summary Hikal Ltd (Hikal) is a pharmaceutical company that provides custom manufacturing; active ingredients and intermediates. The company provides product portfolio such as antiepileptic, antihistamine, antipsychotic and antilipemic, among others. It offers services such as custom synthesis, contr …
  • Corindus Vascular Robotics Inc (CVRS):企業の財務・戦略的SWOT分析
    Summary Corindus Vascular Robotics Inc (Corindus) is a medical device company that designs, manufactures and commercializes remote robotic systems for interventional surgical procedures. The company offers next-generation CorPath GRX system, a robotic platform that enables improvements in procedural …
  • Cedars-Sinai Medical Center:企業のM&A・事業提携・投資動向
    Cedars-Sinai Medical Center - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cedars-Sinai Medical Center Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • BlackBerry Ltd:企業のM&A・事業提携・投資動向
    BlackBerry Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BlackBerry Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Heptares Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Heptares Therapeutics Ltd (Heptares) a subsidiary of Sosei Group Corp is a drug discovery company that develops small-molecule drugs. The company develops drugs for targeting G-protein-coupled receptors by utilizing its drug discovery technology platforms. Its technology platforms comprise S …
  • Willis Towers Watson Public Ltd Co:戦略・SWOT・企業財務分析
    Willis Towers Watson Public Ltd Co - Strategy, SWOT and Corporate Finance Report Summary Willis Towers Watson Public Ltd Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Toei Animation Co., Ltd. (4816):企業の財務・戦略的SWOT分析
    Toei Animation Co., Ltd. (4816) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • EnerMech Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary EnerMech Ltd (EnerMech) is a provider of oilfield services. The company offers cranes and lifting services, hydraulic products and services, pipeline and umbilicals services, valve services, equipment rental, training services and industrial services. Its pipeline and umbilical services comp …
  • INTRUST Financial Corporation:企業の戦略・SWOT・財務情報
    INTRUST Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary INTRUST Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Atopix Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Atopix Therapeutics Ltd (Atopix) is a clinical stage biotechnology company that develops novel treatments for Th2-mediated eosinophilic asthma. The company’s product portfolio includes CRTH2 used in the treatment of atopic dermatitis. It also offers ATX2417 and OC459 used in treatment of ast …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆